Halofenate

SKU: orb3134769

Description

Halofenate is an inhibitor for hypertriglyceridemia, effectively lowering serum triglyceride levels while having minimal impact on serum cholesterol. Additionally, it reduces serum uric acid and promotes uric acid excretion independent of glomerular filtration rate. Halofenate is associated with a significant increase in plasma thyroxine (T4), along with reductions in protein-bound iodine and T4. It can displace T4 from thyroid-binding proteins, which may influence thyroid function in the body.

Research Area

Metabolism Research, Molecular Biology, Signal Transduction, Stem Cell & Developmental Biology

Key Properties

• CAS Number: 26718-25-2
• MW: 415.79
• Formula: C₁₉H₁₇ClF₃NO₄
• SMILES: O=C(OCCNC(=O)C)C(OC1=CC=CC(=C1)C(F)(F)F)C2=CC=C(Cl)C=C2
• Target: PPAR,Wnt/beta-catenin

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

PPAR,Wnt/beta-catenin